Help or hindrance? Rituximab maintenance and COVID Editorial


Author: Noy, A.
Title: Help or hindrance? Rituximab maintenance and COVID
Keywords: rituximab; progression free survival; mantle cell lymphoma; editorial; bendamustine; cyclophosphamide; intensive care unit; hospitalization; hematologic malignancy; antibody response; immunosuppressive treatment; follicular lymphoma; immunocompromised patient; seroconversion; chemoimmunotherapy; human; male; female; article; obinutuzumab; cyclophosphamide plus doxorubicin plus prednisolone plus rituximab plus vincristine; chimeric antigen receptor t-cell immunotherapy; coronavirus disease 2019; vaccine hesitancy
Journal Title: Haematologica
Volume: 110
Issue: 1
ISSN: 0390-6078
Publisher: Ferrata Storti Foundation  
Date Published: 2025-01-01
Start Page: 18
End Page: 19
Language: English
DOI: 10.3324/haematol.2024.286142
PUBMED: 39279441
PROVIDER: scopus
PMCID: PMC11694106
DOI/URL:
Notes: Editorial -- Source: Scopus
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Ariela Noy
    352 Noy